Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Latex Allergy Market

ID: MRFR/MED/18138-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026

US Latex Allergy Market Research Report By Exposure Type (latex gloves, food containing latex substances, others), By Diagnosis Type (skin test, allergy test), By Reaction Type (Systemic Reaction, Allergic contact dermatitis, others) and By Treatment Type (Epinephrine injection, Allergy medication) - Growth & Industry Forecast 2025 To 2035

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Exposure (USD Million)
      1. 4.1.1 Latex gloves
      2. 4.1.2 Food containing latex substances
    2. 4.2 Chemicals and Materials, BY Diagnosis type (USD Million)
      1. 4.2.1 Skin test
      2. 4.2.2 Allergy test
    3. 4.3 Chemicals and Materials, BY Reaction type (USD Million)
      1. 4.3.1 Systemic Reaction
      2. 4.3.2 Allergic contact dermatitis
      3. 4.3.3 Irritant Contact dermatitis
      4. 4.3.4 Asthma
      5. 4.3.5 Anaphylaxis
      6. 4.3.6 Rhinitis
    4. 4.4 Chemicals and Materials, BY Type of treatment (USD Million)
      1. 4.4.1 Epinephrine injection
      2. 4.4.2 Allergy medications: Inhaler or albuterol
      3. 4.4.3 Antihistamine
      4. 4.4.4 Asthma medication
      5. 4.4.5 Corticosteroids
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 B. Braun Melsungen AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Smith & Nephew (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cardinal Health (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hollister Incorporated (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 3M Company (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Coloplast A/S (DK)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY EXPOSURE
    3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS TYPE
    4. 6.4 US MARKET ANALYSIS BY REACTION TYPE
    5. 6.5 US MARKET ANALYSIS BY TYPE OF TREATMENT
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY EXPOSURE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY EXPOSURE, 2024 TO 2035 (USD Million)
    14. 6.14 CHEMICALS AND MATERIALS, BY DIAGNOSIS TYPE, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY DIAGNOSIS TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CHEMICALS AND MATERIALS, BY REACTION TYPE, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY REACTION TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 CHEMICALS AND MATERIALS, BY TYPE OF TREATMENT, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY TYPE OF TREATMENT, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY EXPOSURE, 2025-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSIS TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY REACTION TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY TYPE OF TREATMENT, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Exposure (USD Million, 2025-2035)

  • Latex gloves
  • Food containing latex substances

Chemicals and Materials By Diagnosis type (USD Million, 2025-2035)

  • Skin test
  • Allergy test

Chemicals and Materials By Reaction type (USD Million, 2025-2035)

  • Systemic Reaction
  • Allergic contact dermatitis
  • Irritant Contact dermatitis
  • Asthma
  • Anaphylaxis
  • Rhinitis

Chemicals and Materials By Type of treatment (USD Million, 2025-2035)

  • Epinephrine injection
  • Allergy medications: Inhaler or albuterol
  • Antihistamine
  • Asthma medication
  • Corticosteroids